Long-term risk of secondary skin cancers after radiation therapy for Hodgkin's lymphoma

Radiotherapy and Oncology

Volumn 109, Issue 1, 2013, Pages 140-145

  Daniëls, Laurien A ^a   Krol, Augustinus D G ^a   Schaapveld, Michael ^b,c   Putter, Hein ^a   Jansen, Patty M ^a   Marijt, Erik W A ^a   Van Leeuwen, Flora E ^b,c   Creutzberg, Carien L ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c Department of Cancer Registry and Research   (Netherlands)

Author keywords

Hodgkin's lymphoma; Radiation therapy; Secondary cancers; Skin cancers

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CANCER SURVIVOR; CHEMORADIOTHERAPY; CHILD; COHORT ANALYSIS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; MULTIMODALITY CANCER THERAPY; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION FIELD; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCHOOL CHILD; SKIN CANCER; SQUAMOUS CELL CARCINOMA; STANDARDIZED INCIDENCE RATIO;

HODGKIN'S LYMPHOMA; RADIATION THERAPY; SECONDARY CANCERS; SKIN CANCERS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 84888024799     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.06.041     Document Type: Article

References (37)

1. B.M. Aleman, A.W. van den Belt-Dusebout, and W.J. Klokman Long-term cause-specific mortality of patients treated for Hodgkin's disease J Clin Oncol 21 2003 3431 3439
2. O. Favier, N. Heutte, and A. Stamatoullas-Bastard Survival after Hodgkin lymphoma: causes of death and excess mortality in patients treated in 8 consecutive trials Cancer 115 2009 1680 1691
3. M.D. Morales, F.A. Gonzalez, and A. Villegas Second neoplasms as a late complication of the treatment of Hodgkin's disease Sangre (Barc) 37 1992 429 433
4. F.E. van Leeuwen, W.J. Klokman, and M.B. Veer Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood J Clin Oncol 18 2000 487 497
5. A.K. Ng, M.P. Bernardo, and E. Weller Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger J Clin Oncol 20 2002 2101 2108
6. D.C. Hodgson, E.S. Gilbert, and G.M. Dores Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma J Clin Oncol 25 2007 1489 1497
7. M.L. De Bruin, J. Sparidans, and M.B. Van't Veer Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes J Clin Oncol 27 2009 4239 4246
8. L.B. Travis, D.A. Hill, and G.M. Dores Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease JAMA 290 2003 465 475
9. G.M. Dores, C. Metayer, and R.E. Curtis Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years J Clin Oncol 20 2002 3484 3494
10. A.A. Foss, A. Andersen, and O. Nome Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time Ann Oncol 13 2002 1786 1791
11. A.J. Swerdlow, J.A. Barber, and G.V. Hudson Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment J Clin Oncol 18 2000 498 509
12. A.J. Swerdlow, R. Cooke, and A. Bates Breast cancer risk after supradiaphragmatic radiotherapy for Hodgkin's lymphoma in England and Wales: a National Cohort Study J Clin Oncol 30 2012 2745 2752
13. M.R. Karagas, J.A. McDonald, and E.R. Greenberg Risk of basal cell and squamous cell skin cancers after ionizing radiation therapy. For The Skin Cancer Prevention Study Group J Natl Cancer Inst 88 1996 1848 1853
14. R.E. Shore, R.E. Albert, M. Reed, N. Harley, and B.S. Pasternack Skin cancer incidence among children irradiated for ringworm of the scalp Radiat Res 100 1984 192 204
15. M.D. Lichter, M.R. Karagas, and L.A. Mott Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group Arch Dermatol 136 2000 1007 1011
16. T.C. Watt, P.D. Inskip, and K. Stratton Radiation-related risk of Basal cell carcinoma: a report from the childhood cancer survivor study J Natl Cancer Inst 104 2012 1240 1250
17. A.J. Swerdlow, J.A. Barber, and A. Horwich Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital Br J Cancer 75 1997 116 123
18. J.S. Royle, P. Baade, D. Joske, and L. Fritschi Risk of second cancer after lymphohematopoietic neoplasm Int J Cancer 129 2011 910 919
19. M. Casparie, A.T. Tiebosch, and G. Burger Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive Cell Oncol 29 2007 19 24
20. R.J. van der Leest, L. Liu, and J.W. Coebergh Risk of second primary in situ and invasive melanoma in Dutch population-based cohort: 1 Br J Dermatol 167 6 2012 1321 1330
21. S.C. Flohil, V.E. De, H.A. Neumann, J.W. Coebergh, and T. Nijsten Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands Acta Derm Venereol 91 2011 24 30
22. H. Putter, M. Fiocco, and R.B. Geskus Tutorial in biostatistics: competing risks and multi-state models Stat Med 26 2007 2389 2430
23. L.B. Travis, A.K. Ng, and J.M. Allan Second malignant neoplasms and cardiovascular disease following radiotherapy J Natl Cancer Inst 104 2012 357 370
24. A. Bauer, T.L. Diepgen, and J. Schmitt Is occupational solar ultraviolet irradiation a relevant risk factor for basal cell carcinoma? A systematic review and meta-analysis of the epidemiological literature Br J Dermatol 165 2011 612 625
25. T.L. Diepgen, and V. Mahler The epidemiology of skin cancer Br J Dermatol 146 2002 1 6
26. R. Marks An overview of skin cancers. Incidence and causation Cancer 75 1995 607 612
27. E.M. Noordijk, P. Carde, and N. Dupouy Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials J Clin Oncol 24 2006 3128 3135
28. C. Ferme, H. Eghbali, and J.H. Meerwaldt Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease N Engl J Med 357 2007 1916 1927
29. EORTC 20051-H10 trial. www.eortc.org/research-groups/lymphoma-group/ recent-achievements.
30. J. Thomas, C. Ferme, and E.M. Noordijk Six cycles of EBVP followed by 36 Gy involved-field irradiation vs. no irradiation in favourable supradiaphragmatic clinical stage I-II Hodgkin's lymphoma: the EORTC-GELA strategy in 771 patients Eur J Haematol 73 2004 (s65) abs E11a, 2004 (abstr)
31. E.M. van Leeuwen-Segarceanu, W.J. Bos, and L.D. Dorresteijn Screening Hodgkin lymphoma survivors for radiotherapy induced cardiovascular disease Cancer Treat Rev 37 2011 391 403
32. A.K. Ng Review of the cardiac long-term effects of therapy for Hodgkin lymphoma Br J Haematol 154 2011 23 31
33. S.L. Hess, I.M. Johannsdottir, and H. Hamre Adult survivors of childhood malignant lymphoma are not aware of their risk of late effects Acta Oncol 50 2011 653 659
34. F.E. van Leeuwen, W.J. Klokman, and M. Stovall Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease J Natl Cancer Inst 87 1995 1530 1537
35. A.W. van den Belt-Dusebout, B.M. Aleman, and G. Besseling Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy Int J Radiat Oncol Biol Phys 75 2009 1420 1429
36. F.E. van Leeuwen, W.J. Klokman, and A. Hagenbeek Second cancer risk following Hodgkin's disease: a 20-year follow-up study J Clin Oncol 12 1994 312 325
37. http://www.beternahodgkin.nl.